⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for alvocidib

Every month we try and update this database with for alvocidib cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Flavopiridol in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic LeukemiaNCT00098371
B-cell Chronic ...
Prolymphocytic ...
Refractory Chro...
alvocidib
18 Years - National Cancer Institute (NCI)
Flavopiridol and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer That Has Not Responded to Previous PaclitaxelNCT00006245
Esophageal Canc...
alvocidib
paclitaxel
18 Years - National Cancer Institute (NCI)
Flavopiridol in Treating Patients With Recurrent Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma or Mantle Cell LymphomaNCT00003039
Lymphoma
alvocidib
18 Years - National Cancer Institute (NCI)
Gemcitabine Hydrochloride and Alvocidib in Treating Patients With Solid TumorsNCT00072436
Unspecified Adu...
gemcitabine hyd...
alvocidib
pharmacological...
18 Years - National Cancer Institute (NCI)
Flavopiridol in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous LeukemiaNCT00101231
Adult Acute Bas...
Adult Acute Eos...
Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Blastic Phase C...
Recurrent Adult...
Recurrent Adult...
Relapsing Chron...
alvocidib
1 Year - National Cancer Institute (NCI)
Gemcitabine Plus Flavopiridol in Treating Patients With Advanced Solid TumorsNCT00007917
Unspecified Adu...
alvocidib
gemcitabine hyd...
18 Years - National Cancer Institute (NCI)
Flavopiridol in Treating Patients With Recurrent, Locally Advanced, or Metastatic Soft Tissue SarcomaNCT00005974
Sarcoma
alvocidib
18 Years - 120 YearsCanadian Cancer Trials Group
Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck CancerNCT00020189
Head and Neck C...
Thromboembolism
acetylsalicylic...
alvocidib
clopidogrel bis...
18 Years - National Cancer Institute (NCI)
Flavopiridol in Treating Patients With Recurrent Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma or Mantle Cell LymphomaNCT00003039
Lymphoma
alvocidib
18 Years - National Cancer Institute (NCI)
Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaNCT00634244
Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Recurrent Adult...
alvocidib
mitoxantrone hy...
carboplatin
cytarabine
sirolimus
etoposide
topotecan hydro...
18 Years - 65 YearsNational Cancer Institute (NCI)
Alvocidib, Cytarabine, and Mitoxantrone Hydrochloride or Cytarabine and Daunorubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid LeukemiaNCT01349972
Acute Myeloid L...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Secondary Acute...
Untreated Adult...
alvocidib
daunorubicin hy...
mitoxantrone hy...
cytarabine
18 Years - 70 YearsNational Cancer Institute (NCI)
Combination Chemotherapy in Treating Patients With Refractory or Recurrent Solid TumorsNCT00003004
Unspecified Adu...
alvocidib
cisplatin
paclitaxel
18 Years - Memorial Sloan Kettering Cancer Center
Flavopiridol and Irinotecan in Treating Patients With Advanced Solid TumorsNCT00006485
Unspecified Adu...
alvocidib
irinotecan hydr...
18 Years - National Cancer Institute (NCI)
Flavopiridol and Vorinostat in Treating Patients With Relapsed or Refractory Acute Leukemia or Chronic Myelogenous Leukemia or Refractory AnemiaNCT00278330
Blastic Phase C...
Recurrent Adult...
Recurrent Adult...
Refractory Anem...
Relapsing Chron...
Untreated Adult...
Untreated Adult...
alvocidib
vorinostat
18 Years - National Cancer Institute (NCI)
Flavopiridol in Treating Patients With Recurrent or Persistent Endometrial CancerNCT00023894
Endometrial Can...
alvocidib
- National Cancer Institute (NCI)
Doxorubicin Hydrochloride and Alvocidib in Treating Patients With Metastatic or Recurrent Sarcoma That Cannot Be Removed By SurgeryNCT00098579
Gastrointestina...
Recurrent Adult...
Stage IV Adult ...
alvocidib
doxorubicin hyd...
18 Years - National Cancer Institute (NCI)
Flavopiridol in Treating Patients With Unresectable or Metastatic Kidney CancerNCT00016939
Kidney Cancer
alvocidib
- National Cancer Institute (NCI)
Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid TumorsNCT00042874
Unspecified Adu...
alvocidib
irinotecan hydr...
fluorouracil
leucovorin calc...
laboratory biom...
18 Years - National Cancer Institute (NCI)
Flavopiridol Plus Cisplatin or Carboplatin in Treating Patients With Advanced Solid TumorsNCT00003690
Breast Cancer
Melanoma (Skin)
Prostate Cancer
Unspecified Adu...
alvocidib
carboplatin
cisplatin
18 Years - Mayo Clinic
Flavopiridol and Docetaxel in Treating Patients With Advanced Solid TumorsNCT00016185
Unspecified Adu...
alvocidib
docetaxel
18 Years - Barbara Ann Karmanos Cancer Institute
Docetaxel and Flavopiridol in Treating Patients With Refractory Metastatic Pancreatic CancerNCT00331682
Adenocarcinoma ...
Recurrent Pancr...
Stage IV Pancre...
alvocidib
docetaxel
18 Years - National Cancer Institute (NCI)
Flavopiridol in Treating Patients With Metastatic Malignant MelanomaNCT00005971
Melanoma (Skin)
alvocidib
18 Years - 120 YearsCanadian Cancer Trials Group
Vorinostat and Alvocidib in Treating Patients With Advanced Solid TumorsNCT00324480
Unspecified Adu...
alvocidib
vorinostat
pharmacological...
18 Years - National Cancer Institute (NCI)
Flavopiridol Plus Radiation Therapy Followed By Gemcitabine Hydrochloride in Treating Patients With Locally Advanced, Unresectable Pancreatic CancerNCT00047307
Adenocarcinoma ...
Recurrent Pancr...
Stage II Pancre...
Stage III Pancr...
Stage IV Pancre...
alvocidib
gemcitabine hyd...
3-dimensional c...
laboratory biom...
18 Years - National Cancer Institute (NCI)
Flavopiridol in Treating Patients With Unresectable or Metastatic Kidney CancerNCT00016939
Kidney Cancer
alvocidib
- National Cancer Institute (NCI)
Flavopiridol and Imatinib Mesylate in Treating Patients With Hematologic CancerNCT00064285
Leukemia
alvocidib
imatinib mesyla...
18 Years - Virginia Commonwealth University
Combination Chemotherapy in Treating Patients With Refractory or Recurrent Solid TumorsNCT00003004
Unspecified Adu...
alvocidib
cisplatin
paclitaxel
18 Years - Memorial Sloan Kettering Cancer Center
Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Relapsed or Refractory Acute LeukemiaNCT00470197
Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Malignant Neopl...
Recurrent Adult...
Recurrent Adult...
alvocidib
cytarabine
mitoxantrone hy...
pharmacological...
18 Years - National Cancer Institute (NCI)
Flavopiridol in Treating Patients With Chronic Lymphocytic LeukemiaNCT00003620
B-cell Chronic ...
Refractory Chro...
Stage I Chronic...
Stage II Chroni...
Stage III Chron...
Stage IV Chroni...
alvocidib
laboratory biom...
18 Years - National Cancer Institute (NCI)
Flavopiridol in Treating Patients With Unresectable or Metastatic Kidney CancerNCT00016939
Kidney Cancer
alvocidib
- National Cancer Institute (NCI)
Flavopiridol in Treating Patients With Recurrent Prostate CancerNCT00003256
Prostate Cancer
alvocidib
- National Cancer Institute (NCI)
Alvocidib, Cytarabine, and Mitoxantrone in Treating Patients With Newly Diagnosed Acute Myeloid LeukemiaNCT00407966
Adult Acute Bas...
Adult Acute Eos...
Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Secondary Acute...
Untreated Adult...
alvocidib
cytarabine
mitoxantrone hy...
18 Years - National Cancer Institute (NCI)
Flavopiridol and Irinotecan in Treating Patients With Advanced Solid TumorsNCT00006485
Unspecified Adu...
alvocidib
irinotecan hydr...
18 Years - National Cancer Institute (NCI)
Combination Chemotherapy in Treating Patients With Advanced CancerNCT00021073
Unspecified Adu...
alvocidib
leucovorin calc...
fluorouracil
irinotecan hydr...
18 Years - National Cancer Institute (NCI)
Flavopiridol, Gemcitabine, and Irinotecan in Treating Patients With Unresectable or Metastatic Solid TumorsNCT00079352
Unspecified Adu...
alvocidib
gemcitabine hyd...
irinotecan hydr...
18 Years - National Cancer Institute (NCI)
Alvocidib, Oxaliplatin, Fluorouracil, and Leucovorin Calcium in Treating Patients With Advanced Solid TumorsNCT00080990
Unspecified Adu...
alvocidib
fluorouracil
oxaliplatin
leucovorin calc...
18 Years - National Cancer Institute (NCI)
Flavopiridol and Imatinib Mesylate in Treating Patients With Hematologic CancerNCT00064285
Leukemia
alvocidib
imatinib mesyla...
18 Years - Virginia Commonwealth University
Irinotecan Hydrochloride With or Without Alvocidib in Treating Patients With Advanced Stomach or Gastroesophageal Junction Cancer That Cannot Be Removed By SurgeryNCT00991952
Adenocarcinoma ...
Diffuse Adenoca...
Intestinal Aden...
Mixed Adenocarc...
Recurrent Gastr...
Stage IIIA Gast...
Stage IIIB Gast...
Stage IIIC Gast...
Stage IV Gastri...
alvocidib
irinotecan hydr...
laboratory biom...
18 Years - National Cancer Institute (NCI)
Flavopiridol in Treating Patients With Previously Treated Chronic Lymphocytic Leukemia or Lymphocytic LymphomaNCT00058240
B-cell Chronic ...
Recurrent Small...
Refractory Chro...
Waldenström Mac...
alvocidib
18 Years - National Cancer Institute (NCI)
Flavopiridol Plus Cisplatin or Carboplatin in Treating Patients With Advanced Solid TumorsNCT00003690
Breast Cancer
Melanoma (Skin)
Prostate Cancer
Unspecified Adu...
alvocidib
carboplatin
cisplatin
18 Years - Mayo Clinic
Gemcitabine Hydrochloride and Alvocidib in Treating Patients With Solid TumorsNCT00072436
Unspecified Adu...
gemcitabine hyd...
alvocidib
pharmacological...
18 Years - National Cancer Institute (NCI)
Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck CancerNCT00020189
Head and Neck C...
Thromboembolism
acetylsalicylic...
alvocidib
clopidogrel bis...
18 Years - National Cancer Institute (NCI)
Irinotecan and Flavopiridol in Treating Patients With Advanced Liver CancerNCT00087282
Liver Cancer
alvocidib
irinotecan hydr...
18 Years - National Cancer Institute (NCI)
Flavopiridol in Treating Patients With Previously Treated Chronic Lymphocytic Leukemia or Lymphocytic LymphomaNCT00058240
B-cell Chronic ...
Recurrent Small...
Refractory Chro...
Waldenström Mac...
alvocidib
18 Years - National Cancer Institute (NCI)
Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaNCT00634244
Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Recurrent Adult...
alvocidib
mitoxantrone hy...
carboplatin
cytarabine
sirolimus
etoposide
topotecan hydro...
18 Years - 65 YearsNational Cancer Institute (NCI)
Flavopiridol in Treating Patients With Chronic Lymphocytic LeukemiaNCT00003620
B-cell Chronic ...
Refractory Chro...
Stage I Chronic...
Stage II Chroni...
Stage III Chron...
Stage IV Chroni...
alvocidib
laboratory biom...
18 Years - National Cancer Institute (NCI)
Combination Chemotherapy in Treating Patients With Refractory or Recurrent Solid TumorsNCT00003004
Unspecified Adu...
alvocidib
cisplatin
paclitaxel
18 Years - Memorial Sloan Kettering Cancer Center
Flavopiridol and Docetaxel in Treating Patients With Advanced Solid TumorsNCT00016185
Unspecified Adu...
alvocidib
docetaxel
18 Years - Barbara Ann Karmanos Cancer Institute
Combination Chemotherapy in Treating Patients With Refractory or Recurrent Solid TumorsNCT00003004
Unspecified Adu...
alvocidib
cisplatin
paclitaxel
18 Years - Memorial Sloan Kettering Cancer Center
Vorinostat and Alvocidib in Treating Patients With Advanced Solid TumorsNCT00324480
Unspecified Adu...
alvocidib
vorinostat
pharmacological...
18 Years - National Cancer Institute (NCI)
Ph I Study of Alvocidib and Cytarabine/Daunorubicin (7+3) in Patients With Newly Diagnosed Acute Myeloid Leukemia (AML).NCT03298984
Acute Myeloid L...
Alvocidib
Cytarabine
Daunorubicin
18 Years - 65 YearsSumitomo Pharma America, Inc.
Alvocidib in Treating Patients With B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaNCT00377104
B-cell Chronic ...
Contiguous Stag...
Noncontiguous S...
Stage I Chronic...
Stage I Small L...
Stage II Chroni...
Stage III Chron...
Stage III Small...
Stage IV Chroni...
Stage IV Small ...
alvocidib
pharmacological...
laboratory biom...
18 Years - National Cancer Institute (NCI)
Alvocidib in Treating Patients With B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaNCT00377104
B-cell Chronic ...
Contiguous Stag...
Noncontiguous S...
Stage I Chronic...
Stage I Small L...
Stage II Chroni...
Stage III Chron...
Stage III Small...
Stage IV Chroni...
Stage IV Small ...
alvocidib
pharmacological...
laboratory biom...
18 Years - National Cancer Institute (NCI)
Alvocidib, Fludarabine Phosphate, and Rituximab in Treating Patients With Lymphoproliferative Disorders or Mantle Cell LymphomaNCT00058227
B-cell Chronic ...
Contiguous Stag...
Contiguous Stag...
Contiguous Stag...
Contiguous Stag...
Contiguous Stag...
Extranodal Marg...
Nodal Marginal ...
Noncontiguous S...
Noncontiguous S...
Noncontiguous S...
Noncontiguous S...
Noncontiguous S...
Progressive Hai...
Recurrent Grade...
Recurrent Grade...
Recurrent Mantl...
Recurrent Margi...
Recurrent Small...
Refractory Chro...
Refractory Hair...
Splenic Margina...
Stage I Chronic...
Stage I Grade 1...
Stage I Grade 2...
Stage I Mantle ...
Stage I Margina...
Stage I Small L...
Stage II Chroni...
Stage III Chron...
Stage III Grade...
Stage III Grade...
Stage III Mantl...
Stage III Margi...
Stage III Small...
Stage IV Chroni...
Stage IV Grade ...
Stage IV Grade ...
Stage IV Mantle...
Stage IV Margin...
Stage IV Small ...
Untreated Hairy...
Waldenström Mac...
alvocidib
fludarabine pho...
rituximab
pharmacological...
18 Years - National Cancer Institute (NCI)
Alvocidib Biomarker-driven Phase 2 AML StudyNCT02520011
Acute Myeloid L...
Alvocidib
Cytarabine
Mitoxantrone
18 Years - 65 YearsSumitomo Pharma America, Inc.
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: